Gopal Ramakrishnan

783 total citations · 1 hit paper
7 papers, 598 citations indexed

About

Gopal Ramakrishnan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Gopal Ramakrishnan has authored 7 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Gopal Ramakrishnan's work include Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Gopal Ramakrishnan is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Gopal Ramakrishnan collaborates with scholars based in India and United States. Gopal Ramakrishnan's co-authors include Ali Khojasteh, Madhavan Krishnan Nair, Karen Hoelzer, Troy H. Guthrie, Pankaj Shah, Katherine H. R. Tkaczuk, John Gutheil, Gerald Batist, Suresh H. Advani and Shanti Swaroop and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Gopal Ramakrishnan

7 papers receiving 576 citations

Hit Papers

Reduced Cardiotoxicity and Preserved Antitumor Efficacy o... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer
    2001 507 citations Gerald Batist, Gopal Ramakrishnan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gopal Ramakrishnan India 6 240 193 191 123 109 7 598
J Whittaker United States 4 228 0.9× 90 0.5× 226 1.2× 157 1.3× 119 1.1× 8 510
M. Clemons Canada 8 383 1.6× 179 0.9× 79 0.4× 82 0.7× 57 0.5× 24 551
L Roman Russia 6 288 1.2× 73 0.4× 138 0.7× 123 1.0× 60 0.6× 9 676
Agustin Garcia United States 4 263 1.1× 65 0.3× 171 0.9× 170 1.4× 80 0.7× 7 715
Gurpreet Lamba United States 8 113 0.5× 113 0.6× 103 0.5× 107 0.9× 65 0.6× 22 464
Linda J. Paradiso United States 9 245 1.0× 65 0.3× 129 0.7× 194 1.6× 61 0.6× 20 701
Arbuck Sg United States 7 498 2.1× 49 0.3× 97 0.5× 150 1.2× 41 0.4× 10 725
Shamudheen Mohammed Rafiyath United States 5 102 0.4× 68 0.4× 103 0.5× 115 0.9× 66 0.6× 7 432
Adelina Curaj Germany 15 148 0.6× 229 1.2× 46 0.2× 231 1.9× 137 1.3× 30 756
Guofan Qu China 9 301 1.3× 67 0.3× 65 0.3× 150 1.2× 241 2.2× 28 738

Countries citing papers authored by Gopal Ramakrishnan

Since Specialization
Citations

This map shows the geographic impact of Gopal Ramakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopal Ramakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopal Ramakrishnan more than expected).

Fields of papers citing papers by Gopal Ramakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopal Ramakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopal Ramakrishnan. The network helps show where Gopal Ramakrishnan may publish in the future.

Co-authorship network of co-authors of Gopal Ramakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Gopal Ramakrishnan. A scholar is included among the top collaborators of Gopal Ramakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopal Ramakrishnan. Gopal Ramakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Singh, Tejinder P., et al.. (2016). Combined prednisolone and pirfenidone in bleomycin-induced lung disease. Journal of Cancer Research and Therapeutics. 12(3). 1198–1202. 9 indexed citations
2.
Batist, Gerald, Gopal Ramakrishnan, John Gutheil, et al.. (2001). Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer. Journal of Clinical Oncology. 19(5). 1444–1454. 507 indexed citations breakdown →
3.
4.
5.
Saikia, Tapan, et al.. (1988). Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping—Experience in 60 patients. Leukemia Research. 12(6). 499–506. 26 indexed citations
6.
Advani, Suresh H., Shanti Swaroop, Gopal Ramakrishnan, et al.. (1985). Anterior chemotherapy in esophageal cancer. Cancer. 56(7). 1502–1506. 20 indexed citations
7.
Advani, Suresh H., Ketayun A. Dinshaw, Chandrika N. Nair, & Gopal Ramakrishnan. (1983). Total body irradiation in chronic myeloid leukemia. International Journal of Radiation Oncology*Biology*Physics. 9(4). 497–500. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Whittaker Breakdown of academic impact, for papers by M. Clemons Breakdown of academic impact, for papers by L Roman Breakdown of academic impact, for papers by Agustin Garcia Breakdown of academic impact, for papers by Gurpreet Lamba Breakdown of academic impact, for papers by Linda J. Paradiso Breakdown of academic impact, for papers by Arbuck Sg Breakdown of academic impact, for papers by Shamudheen Mohammed Rafiyath Breakdown of academic impact, for papers by Adelina Curaj Breakdown of academic impact, for papers by Guofan Qu
Rankless by CCL
2026